Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer.

Asian Pacific journal of cancer prevention : APJCP - 1 Apr 2023

Gautam Kirti Amresh, Raghav Alok, Sankhwar S N, Singh Rajender, Tripathi Prashant

Abstract excerpt

Methionine synthase reductase (MTRR) gene involved in the signaling for production of enzyme called methionine synthase reductase that use for the synthesis of methionine, which further used in DNA replication and repair. Genetic variation in MTRR gene may alter the susceptibility of developing urinary bladder cancer. The present study undertaken to identify the contribution of genetic polymorphisms in the MTRR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ferredoxin-NADP Reductase

Share to Genetic Predisposition to Disease

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Polymorphism, Genetic

Share to Risk Factors

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37116134
DOI: 10.31557/APJCP.2023.24.4.1137
PMCID: PMC10352732

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer.PMID 37116134Read ↗

Association of Human Methionine Synthase-A2756G Transition With Prostate Cancer: A Case-Control Study and in Silico Analysis.Semantic proximity Read ↗

Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.Semantic proximity Read ↗

MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.Semantic proximity Read ↗

Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors.Semantic proximity Read ↗

Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.Semantic proximity Read ↗

The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.Semantic proximity Read ↗

Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis.Semantic proximity Read ↗

Genetic polymorphism in bladder cancer.Semantic proximity Read ↗

MTHFR gene polymorphisms in bladder cancer in the Turkish population.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.